|
|
The Life Insurance Market
|
Critical illness cover premiums could be less costly for consumers in the future thanks to the potential of a new development for the treatment of MS.
Progress made on drugs in a study with rats by Cambridge and Edinburgh University, suggests scientists have identified how to prompt stem cells to regenerate the myelin sheath.
This part of central nervous system is at the centre of multiple sclerosis problems.
Consumers comparing critical illness cover will no doubt join MS charities in welcoming the findings and the hope they offer in the restoring of motor functions.
Around 100,000 people in the UK are believed to have multiple sclerosis.
Critical illness cover would provide financial security for treatment, or when a consumer is unable to work.
Chief executive of the MS Society, Simon Gillespie says: "It's hard to put into words how revolutionary this discovery could be." 
--
0
comments:
-
Post your own comment
|
|
|